PRTN3 and atherosclerosis: Besides, given that anti-citrullinated peptide antibody (ACPA) positive RA patients exhibit a higher risk of ASCVD compared to those without ACPA [17,18], lipid/metabolomics might be a useful tool to find the differential HDL-related metabolites linked to ACPA positivity.